1. Home
  2. CERO vs GSUN Comparison

CERO vs GSUN Comparison

Compare CERO & GSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • GSUN
  • Stock Information
  • Founded
  • CERO 2017
  • GSUN 1997
  • Country
  • CERO United States
  • GSUN China
  • Employees
  • CERO N/A
  • GSUN N/A
  • Industry
  • CERO
  • GSUN Other Consumer Services
  • Sector
  • CERO
  • GSUN Real Estate
  • Exchange
  • CERO Nasdaq
  • GSUN Nasdaq
  • Market Cap
  • CERO 6.1M
  • GSUN 6.1M
  • IPO Year
  • CERO N/A
  • GSUN 2022
  • Fundamental
  • Price
  • CERO $5.39
  • GSUN $2.34
  • Analyst Decision
  • CERO Strong Buy
  • GSUN
  • Analyst Count
  • CERO 2
  • GSUN 0
  • Target Price
  • CERO $45.00
  • GSUN N/A
  • AVG Volume (30 Days)
  • CERO 82.8K
  • GSUN 13.6K
  • Earning Date
  • CERO 11-18-2025
  • GSUN 10-17-2025
  • Dividend Yield
  • CERO N/A
  • GSUN N/A
  • EPS Growth
  • CERO N/A
  • GSUN N/A
  • EPS
  • CERO N/A
  • GSUN N/A
  • Revenue
  • CERO N/A
  • GSUN $25,314,724.00
  • Revenue This Year
  • CERO N/A
  • GSUN N/A
  • Revenue Next Year
  • CERO N/A
  • GSUN N/A
  • P/E Ratio
  • CERO N/A
  • GSUN N/A
  • Revenue Growth
  • CERO N/A
  • GSUN 526.22
  • 52 Week Low
  • CERO $4.27
  • GSUN $1.82
  • 52 Week High
  • CERO $895.40
  • GSUN $5.25
  • Technical
  • Relative Strength Index (RSI)
  • CERO 40.84
  • GSUN 35.68
  • Support Level
  • CERO $5.18
  • GSUN $2.36
  • Resistance Level
  • CERO $5.45
  • GSUN $2.72
  • Average True Range (ATR)
  • CERO 0.24
  • GSUN 0.17
  • MACD
  • CERO 0.09
  • GSUN -0.06
  • Stochastic Oscillator
  • CERO 56.96
  • GSUN 0.00

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

About GSUN Golden Sun Education Group Limited

Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.

Share on Social Networks: